Literature DB >> 4066912

Association of slime with pathogenicity of coagulase-negative staphylococci causing nosocomial septicemia.

M A Ishak, D H Gröschel, G L Mandell, R P Wenzel.   

Abstract

To assess the role of slime in the pathogenesis of nosocomial bloodstream infections caused by coagulase-negative staphylococci, we compared the characteristics of 27 nosocomial bloodstream isolates with those of 27 skin isolates from non-hospital personnel. Of 27 bloodstream isolates, 14 were judged to be significant by a clinical index, and 13 were contaminants. Slime production was observed in 13 of 14 significant isolates but in only 3 of 13 contaminants (P = 0.0003) and 4 of 27 skin isolates (P = 0.0001). The 14 pathogens were identified as Staphylococcus epidermidis. Only 7 of 13 contaminants and 9 of 27 skin isolates belonged to the same species (P less than 0.006). Slime-producing strains of S. epidermidis represented 13 of 14 pathogens but only 2 of 13 contaminants (P less than 0.0003). Neither adherence to Teflon catheters nor phagocytosis and killing of coagulase-negative staphylococci by polymorphonuclear leukocytes was significantly influenced by slime production. Nevertheless, the identity of the organism and the slime production test predicted the clinical significance of blood isolates of coagulase-negative staphylococci with an overall accuracy of 89%.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4066912      PMCID: PMC271871          DOI: 10.1128/jcm.22.6.1025-1029.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  THE CLASSIFICATION OF STAPHYLOCOCCI AND MICROCOCCI FROM WORLD-WIDE SOURCES.

Authors:  A C BAIRD-PARKER
Journal:  J Gen Microbiol       Date:  1965-03

2.  Excessive production of mucoid substance in staphylococcus SIIA: a possible factor in colonisation of Holter shunts.

Authors:  R Bayston; S R Penny
Journal:  Dev Med Child Neurol Suppl       Date:  1972

3.  Therapy of staphylococcus epidermidis: infections associated with cerebrospinal fluid shunts.

Authors:  D B Shurtleff; E L Foltz; R D Weeks; J Loeser
Journal:  Pediatrics       Date:  1974-01       Impact factor: 7.124

4.  Fimbriae and adhesive properties in Salmonellae.

Authors:  J P Duguid; E S Anderson; I Campbell
Journal:  J Pathol Bacteriol       Date:  1966-07

5.  Mucosal adherence of human enteropathogenic Escherichia coli.

Authors:  A S McNeish; P Turner; J Fleming; N Evans
Journal:  Lancet       Date:  1975-11-15       Impact factor: 79.321

6.  Staphylococcus epidermidis: an important pathogen.

Authors:  R A Forse; C Dixon; K Bernard; L Martinez; A P McLean; J L Meakins
Journal:  Surgery       Date:  1979-09       Impact factor: 3.982

7.  Studies of introital colonization in women with recurrent urinary infections. VII. The role of bacterial adherence.

Authors:  J E Fowler; T A Stamey
Journal:  J Urol       Date:  1977-04       Impact factor: 7.450

8.  M protein-associated adherence of Streptococcus pyogenes to epithelial surfaces: prerequisite for virulence.

Authors:  R P Ellen; R J Gibbons
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

9.  Vascular prosthetic infections: collected experience and results of treatment.

Authors:  W G Liekweg; L J Greenfield
Journal:  Surgery       Date:  1977-03       Impact factor: 3.982

10.  Catheter sepsis due to Staphylococcus epidermidis during parenteral nutrition.

Authors:  A Sitges-Serra; P Puig; E Jaurrieta; J Garau; A Alastrue; A Sitges-Creus
Journal:  Surg Gynecol Obstet       Date:  1980-10
View more
  48 in total

1.  Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model.

Authors:  M E Rupp; J S Ulphani; P D Fey; K Bartscht; D Mack
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Adherence measured by microtiter assay as a virulence marker for Staphylococcus epidermidis infections.

Authors:  M A Deighton; B Balkau
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

3.  Characterization of a proteinaceous adhesin of Staphylococcus epidermidis which mediates attachment to polystyrene.

Authors:  C P Timmerman; A Fleer; J M Besnier; L De Graaf; F Cremers; J Verhoef
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

4.  Blood proteins do not promote adherence of coagulase-negative staphylococci to biomaterials.

Authors:  E Muller; S Takeda; D A Goldmann; G B Pier
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

5.  Effects of subinhibitory concentrations of vancomycin or cefamandole on biofilm production by coagulase-negative staphylococci.

Authors:  W M Dunne
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

6.  Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide intercellular adhesin.

Authors:  D Mack; M Nedelmann; A Krokotsch; A Schwarzkopf; J Heesemann; R Laufs
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Role of the Staphylococcus epidermidis slime layer in experimental tunnel tract infections.

Authors:  C C Patrick; M R Plaunt; S V Hetherington; S M May
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Staphylococcal exopolysaccharides inhibit lymphocyte proliferative responses by activation of monocyte prostaglandin production.

Authors:  R D Stout; K P Ferguson; Y N Li; D W Lambe
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  [The role of coagulase negative staphylococci in mixed infections: association testing as an in vitro model].

Authors:  K H Manncke; W R Heizmann
Journal:  Langenbecks Arch Chir       Date:  1989

10.  Regulation of slime production in Staphylococcus epidermidis by iron limitation.

Authors:  M Deighton; R Borland
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.